Wert20212022202320242025TTMMittelzufluss aus Investitionstätigkeit-481 M-420 M-260 M-513 M-390 M168 MZahlungsströme aus der Finanzierungstätigkeit-1.33 B-433 M-569 M-368 M-561 M-524 MFreier Cashflow2.07 B538 M546 M939 M414 M614 M
Organon & Co. Common Stock
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.